SCHEMBL6922111

SCHEMBL6922111

CC1CCCC/C1=N\O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8463136 1.00
SCHEMBL4359123 1.00
SCHEMBL6890106 0.98 KMT2A (0.46)
SCHEMBL1663015 0.93
SCHEMBL1663017 0.93
SCHEMBL8691688 0.82
SCHEMBL22695495 0.80 KMT2A (0.36)
SCHEMBL8744012 0.78
SCHEMBL8744017 0.78
SCHEMBL12529300 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026101924-A1 KRAS MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2026-05-15 WO disclosed
US-20190055204-A1 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. 2019-02-21 US disclosed
US-10011559-B2 Preparation of chiral amides and amines SUNOVION PHARMACEUTICALS INC. (US) 2018-07-03 US disclosed
US-20180016224-A1 PREPARATION OF CHIRAL AMIDES AND AMINES SUNOVION PHARMACEUTICALS INC. 2018-01-18 US disclosed
EP-2816024-B1 Chiral amines SUNOVION PHARMACEUTICALS INC (US) 2017-08-02 EP disclosed
US-20160016891-A1 PREPARATION OF CHIRAL AMIDES AND AMINES SUNOVION PHARMACEUTICALS INC. 2016-01-21 US disclosed
US-20160016891-A1 PREPARATION OF CHIRAL AMIDES AND AMINES SUNOVION PHARMACEUTICALS INC. 2016-01-21 US disclosed
EP-2013835-B1 PREPARATION OF CHIRAL AMIDES AND AMINES SUNOVION PHARMACEUTICALS INC (US) 2015-11-04 EP disclosed
EP-2816024-A1 Chiral amines Sunovion Pharmaceuticals Inc. (US) 2014-12-24 EP disclosed
US-20140349992-A1 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2014-11-27 US disclosed
EP-0696273-A1 CARBAMOYL HYDROXYLAMINE AND USE THEREOF IN POLYMER CHEMISTRY BASF AG (DE) 1996-02-14 EP disclosed
WO-1995012626-A1 AQUEOUS PAINTS AND THEIR USE TO PRODUCE FILLER LAYERS IN AUTOMOBILE PAINTING BASF LACKE + FARBEN AG (DE) 1995-05-11 WO disclosed
WO-1995008597-A1 ELECTRO-DIPCOATING PAINT AND PROCESS FOR DIP-COATING ELECTROCONDUCTIVE SUBSTRATES BASF LACKE + FARBEN AG (DE) 1995-03-30 WO disclosed
WO-1995000593-A2 ELECTROPHORETIC ENAMEL AND PROCESS FOR LACQUERING ELECTROCONDUCTIVE SUBSTRATES BASF LACKE + FARBEN AG (DE) 1995-01-05 WO disclosed
WO-1994025433-A1 CARBAMOYL HYDROXYLAMINE AND USE THEREOF IN POLYMER CHEMISTRY BASF AKTIENGESELLSCHAFT (DE) 1994-11-10 WO disclosed
EP-0617012-A1 Beta-hydroxy oxime ethers and dispersions or solutions which are cross-linkable at room temperature by beta-hydroxy oxime ethers BASF Aktiengesellschaft (DE) 1994-09-28 EP disclosed
EP-0596291-A1 Copolymers curing at room temperature BASF Aktiengesellschaft (DE) 1994-05-11 EP disclosed
EP-0522306-A1 Room temperature curing aqueous synthetic resin composition and its use as laminating adhesive BASF Aktiengesellschaft (DE) 1993-01-13 EP disclosed
EP-0016446-B1 PROCESS FOR THE PREPARATION OF O,N-DISUBSTITUTED HYDROXYL AMINES BASF Aktiengesellschaft (DE) 1982-06-02 EP disclosed
EP-0016446-A1 Process for the preparation of O,N-disubstituted hydroxyl amines BASF Aktiengesellschaft (DE) 1980-10-01 EP disclosed